Herrmann S, Mescher M
Proc Natl Acad Sci U S A. 1981; 78(4):2488-92.
PMID: 6972537
PMC: 319372.
DOI: 10.1073/pnas.78.4.2488.
Finberg R, Weiner H, Burakoff S, Fields B
Infect Immun. 1981; 31(2):646-9.
PMID: 6971263
PMC: 351358.
DOI: 10.1128/iai.31.2.646-649.1981.
Weinberger O, Herrmann S, Mescher M, Benacerraf B, Burakoff S
Proc Natl Acad Sci U S A. 1980; 77(10):6091-5.
PMID: 6969401
PMC: 350219.
DOI: 10.1073/pnas.77.10.6091.
Braciale T, Mojcik C, Hauptfeld V
Immunogenetics. 1982; 15(1):41-52.
PMID: 6177628
DOI: 10.1007/BF00375501.
Abbas A, Burakoff S, Gefter M, Greene M
J Exp Med. 1980; 152(4):969-78.
PMID: 6158552
PMC: 2185970.
DOI: 10.1084/jem.152.4.969.
T lymphocyte-mediated suppression of myeloma function in vitro. II. Evidence for regulation of hapten-binding myelomas by syngeneic hapten-specific cytolytic T lymphocytes.
Abbas A, Ratnofsky S, Burakoff S
J Exp Med. 1980; 152(2):306-23.
PMID: 6156985
PMC: 2185947.
DOI: 10.1084/jem.152.2.306.
Generation of cytolytic T lymphocytes in thymectomized, irradiated, and bone marrow-reconstituted mice.
Duprez V, Hamilton B, Burakoff S
J Exp Med. 1982; 156(3):844-59.
PMID: 6125557
PMC: 2186799.
DOI: 10.1084/jem.156.3.844.
Inhibition of antiskin allograft immunity induced by infusions with photoinactivated effector T lymphocytes (PET cells).
Perez M, Edelson R, John L, Laroche L, Berger C
Yale J Biol Med. 1989; 62(6):595-609.
PMID: 2636801
PMC: 2589148.
Cross-reactive lysis of trinitrophenyl (TNP)-derivatized H-2 incompatible target cells by cytolytic T lymphocytes generated against syngeneic TNP spleen cells.
Burakoff S, Germain R, Benacerraf B
J Exp Med. 1976; 144(6):1609-20.
PMID: 1087327
PMC: 2190486.
DOI: 10.1084/jem.144.6.1609.
Soluble factors in tolerance and contact sensitivity to 2,4-dinitrofluorobenzene in mice. III. Histocompatibility antigens associated with the hapten dinitrophenol serve as target molecules on 2,4-dinitrofluorobenzene-immune T cells for soluble....
Moorhead J
J Exp Med. 1979; 150(6):1432-47.
PMID: 315993
PMC: 2185740.
DOI: 10.1084/jem.150.6.1432.
The induction of secondary cytolytic T lymphocytes by solubilized membrane proteins.
Mescher M, Sherman L, Lemonnier F, Burakoff S
J Exp Med. 1978; 147(3):946-51.
PMID: 305464
PMC: 2184210.
DOI: 10.1084/jem.147.3.946.
The generation of killer cells to trinitrophenyl-modified allogeneic targets by lymphocyte populations negatively selected to strong alloantigens.
Wilson D, Lindahl K, Wilson D, Sprent J
J Exp Med. 1977; 146(2):361-7.
PMID: 301550
PMC: 2180779.
DOI: 10.1084/jem.146.2.361.
Cytolytic thymus-derived lymphocytes specific for allogeneic stimulator cells crossreact with chemically modified syngeneic cells.
Proc Natl Acad Sci U S A. 1977; 74(3):1229-33.
PMID: 300484
PMC: 430656.
DOI: 10.1073/pnas.74.3.1229.
Generation of cytolytic T lymphocytes after reovirus infection: role of S1 gene.
Finberg R, Weiner H, Fields B, Benacerraf B, Burakoff S
Proc Natl Acad Sci U S A. 1979; 76(1):442-6.
PMID: 218202
PMC: 382956.
DOI: 10.1073/pnas.76.1.442.
Biological significance of alloreactivity: T cells stimulated by Sendai virus-coated syngeneic cells specifically lyse allogeneic target cells.
Finberg R, Burakoff S, CANTOR H, Benacerraf B
Proc Natl Acad Sci U S A. 1978; 75(10):5145-9.
PMID: 217013
PMC: 336281.
DOI: 10.1073/pnas.75.10.5145.
The induction of virus-specific cytotoxic T lymphocytes with solubilized viral and membrane proteins.
Finberg R, Mescher M, Burakoff S
J Exp Med. 1978; 148(6):1620-7.
PMID: 214512
PMC: 2185092.
DOI: 10.1084/jem.148.6.1620.
The biologic significance of alloreactivity. The ontogeny of T-cell sets specific for alloantigens or modified self antigens.
Burakoff S, Finberg R, Glimcher L, Lemonnier F, Benacerraf B, CANTOR H
J Exp Med. 1978; 148(5):1414-22.
PMID: 214510
PMC: 2185050.
DOI: 10.1084/jem.148.5.1414.
Hapten-specific T-cell responses to 4-hydroxy-3-nitrophenyl acetyl. I. Genetic control of delayed-type hypersensitivity by VH and I-A-region genes.
Weinberger J, Greene M, Benacerraf B, Dorf M
J Exp Med. 1979; 149(6):1336-48.
PMID: 109567
PMC: 2184899.
DOI: 10.1084/jem.149.6.1336.
Genetic control of cytolytic T-lymphocyte responses. I. Ir gene control of the specificity of cytolytic T-lymphocyte responses to trinitrophenyl-modified syngeneic cells.
Billings P, Burakoff S, Dorf M, Benacerraf B
J Exp Med. 1978; 148(2):341-50.
PMID: 100567
PMC: 2184941.
DOI: 10.1084/jem.148.2.341.
Lymphocytes. 1. Function. Genetic restrictions in the immune response.
McMichael A
J Clin Pathol Suppl (R Coll Pathol). 1979; 13:30-8.
PMID: 93114
PMC: 1521587.
DOI: 10.1136/jcp.s3-13.1.30.